tetano
Editor, Senior Moderator
Rev Clin Esp (Barc)
. 2021 Jun 12;S2254-8874(21)00109-0.
doi: 10.1016/j.rceng.2021.01.004. Online ahead of print.
Pulmonary embolism during SARS-CoV-2 pandemic: Clinical and radiological features
A García-Lledó[SUP] 1 [/SUP], M Del Palacio-Salgado[SUP] 2 [/SUP], C Álvarez-Sanz[SUP] 3 [/SUP], M M Pérez-Gil[SUP] 4 [/SUP], Á Cruz-Díaz[SUP] 3 [/SUP]
Affiliations
Abstract
Background: A high incidence of pulmonary embolism has been described during the coronavirus pandemic.
Methods: This work is a single-center retrospective study which reviewed computed tomography pulmonary angiograms ordered due to suspected pulmonary embolism during two periods: from March 1, 2020 to May 31, 2020 (pandemic) and during the same interval in 2019 (control).
Results: Twenty-two pulmonary embolisms were diagnosed during the control period and 99 in the pandemic, 74 of which were associated with COVID-19. Of all patients hospitalized with COVID-19, 5.3% had a pulmonary embolism, with a delay between the two diagnoses of 9.1 ± 8.4 days. During the pandemic, patients with pulmonary embolism had fewer predisposing conditions (previous pulmonary embolism 5.1 vs. 18.2%, p = .05; previous surgery 2 vs. 35.4%, p = .0001; deep vein thrombosis 11.1 vs. 45.5%, p = .0001); peripheral pulmonary embolisms were the most frequent (73.5 vs. 50%, p = . 029).
Conclusions: There is an increased risk of having a pulmonary embolism during the SARS-CoV-2 pandemic, which affects patients with a different clinical profile and more often causes distal pulmonary embolisms.
Keywords: COVID-19; Coronavirus; Embolismo pulmonar; Pulmonary embolism; SARS-CoV-2; Thrombosis; Trombosis.
. 2021 Jun 12;S2254-8874(21)00109-0.
doi: 10.1016/j.rceng.2021.01.004. Online ahead of print.
Pulmonary embolism during SARS-CoV-2 pandemic: Clinical and radiological features
A García-Lledó[SUP] 1 [/SUP], M Del Palacio-Salgado[SUP] 2 [/SUP], C Álvarez-Sanz[SUP] 3 [/SUP], M M Pérez-Gil[SUP] 4 [/SUP], Á Cruz-Díaz[SUP] 3 [/SUP]
Affiliations
- PMID: 34147421
- DOI: 10.1016/j.rceng.2021.01.004
Abstract
Background: A high incidence of pulmonary embolism has been described during the coronavirus pandemic.
Methods: This work is a single-center retrospective study which reviewed computed tomography pulmonary angiograms ordered due to suspected pulmonary embolism during two periods: from March 1, 2020 to May 31, 2020 (pandemic) and during the same interval in 2019 (control).
Results: Twenty-two pulmonary embolisms were diagnosed during the control period and 99 in the pandemic, 74 of which were associated with COVID-19. Of all patients hospitalized with COVID-19, 5.3% had a pulmonary embolism, with a delay between the two diagnoses of 9.1 ± 8.4 days. During the pandemic, patients with pulmonary embolism had fewer predisposing conditions (previous pulmonary embolism 5.1 vs. 18.2%, p = .05; previous surgery 2 vs. 35.4%, p = .0001; deep vein thrombosis 11.1 vs. 45.5%, p = .0001); peripheral pulmonary embolisms were the most frequent (73.5 vs. 50%, p = . 029).
Conclusions: There is an increased risk of having a pulmonary embolism during the SARS-CoV-2 pandemic, which affects patients with a different clinical profile and more often causes distal pulmonary embolisms.
Keywords: COVID-19; Coronavirus; Embolismo pulmonar; Pulmonary embolism; SARS-CoV-2; Thrombosis; Trombosis.